Format

Send to

Choose Destination
See comment in PubMed Commons below
Circ Res. 2012 Jul 20;111(3):375-85. doi: 10.1161/CIRCRESAHA.110.223842.

Understanding cardiomyopathy phenotypes based on the functional impact of mutations in the myosin motor.

Author information

1
Department of Physiology and Biophysics, Boston University School of Medicine, Boston, MA 02118, USA. jxmoore@bu.edu

Abstract

Hypertrophic (HCM) and dilated (DCM) cardiomyopathies are inherited diseases with a high incidence of death due to electric abnormalities or outflow tract obstruction. In many of the families afflicted with either disease, causative mutations have been identified in various sarcomeric proteins. In this review, we focus on mutations in the cardiac muscle molecular motor, myosin, and its associated light chains. Despite the >300 identified mutations, there is still no clear understanding of how these mutations within the same myosin molecule can lead to the dramatically different clinical phenotypes associated with HCM and DCM. Localizing mutations within myosin's molecular structure provides insight into the potential consequence of these perturbations to key functional domains of the motor. Review of biochemical and biophysical data that characterize the functional capacities of these mutant myosins suggests that mutant myosins with enhanced contractility lead to HCM, whereas those displaying reduced contractility lead to DCM. With gain and loss of function potentially being the primary consequence of a specific mutation, how these functional changes trigger the hypertrophic response and lead to the distinct HCM and DCM phenotypes will be the future investigative challenge.

PMID:
22821910
PMCID:
PMC3947556
DOI:
10.1161/CIRCRESAHA.110.223842
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center